Showing 3151-3160 of 4848 results for "".
Topical Corticosteroids and Topical Calcineurin Inhibitors in Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/topical-corticosteroids-and-topical-calcineurin-inhibitors-atopic-dermatitis/29118/Analysis of a 2024 study by Gether et al., in which the authors compared the effectiveness of topical corticosteroids (TCS) and topical calcineurin inhibitors (TCIs) in adults with atopic dermatitis (AD).Currents: Targeted Opportunities
https://practicaldermatology.com/topics/practice-management/currents-targeted-opportunities/23097/Reach your goals in dermatology practice.The Clinical Significance of Gene Expression Profile Testing for Melanoma
https://practicaldermatology.com/topics/practice-management/the-clinical-significance-of-gene-expression-profile-testing-for-melanoma/20647/Accumulated evidence on GEP Classification suggests that it provides clinically relevant information that can influence patient management for the better.Your MIPS 2018 Reporting Cheat Sheet
https://practicaldermatology.com/topics/practice-management/your-mips-2018-reporting-cheat-sheet/20478/Follow this advice to avoid a penalty in 2020.For the record, I forgot to mention…
https://practicaldermatology.com/topics/practice-management/for-the-record-i-forgot-to-mention/20692/Revisiting Hydrotherapy
https://practicaldermatology.com/topics/general-topics/revisiting-hydrotherapy/21028/Cutaneous Manifestations Associated with Nemolizumab
https://practicaldermatology.com/issues/september-2025/cutaneous-manifestations-associated-with-nemolizumab/37628/In the 2025 study by Sasaki et al entitled “Clinical characteristics and risk factors for cutaneous manifestations associated with nemolizumab in atopic dermatitis: a multicenter retrospective study in Japan,” nemolizumab-induced cutaneous eruptions were found to be relatively common, typically occuPreparing for Private Equity: Benefits and Drawbacks
https://practicaldermatology.com/issues/september-2025/preparing-for-private-equity-benefits-and-drawbacks/37629/Over the past decade, the health care industry has emerged as a prime target for private equity (PE) investment.Who's Afraid of the Big Black Box?
https://practicaldermatology.com/topics/psoriasis/whos-afraid-of-the-big-black-box/20286/New Products
https://practicaldermatology.com/topics/practice-management/new-products/21183/